Also categorized in BoardNews:
Netflix: Icahn Says Poison Pill 'Poor Corporate Governance'
x hide permanently

Corporate governance failure at Ranbaxy?

Business Standard

Ranbaxy's criminal guilty plea and $500 million in fines and penalties has brought back the spotlight on corporate governance. The criminal case focused on sales in the US market. However, if media reports are to be believed, Ranbaxy committed systemic fraud in its worldwide regulatory filings.